Michael Michal
Overview
Explore the profile of Michael Michal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Macedo R, Baranovska-Andrigo V, Pancsa T, Klubickova N, Rubin B, Kilpatrick S, et al.
Histopathology
. 2024 Oct;
86(3):423-432.
PMID: 39381843
Aims: CIC-rearranged sarcomas (CRS) are clinically aggressive undifferentiated round cell sarcomas (URCS), commonly driven by CIC::DUX4. Due to the repetitive nature of DUX4 and the variability of the fusion breakpoints,...
12.
Kalmykova A, Baranovska-Andrigo V, Michal M
Virchows Arch
. 2024 Sep;
485(5):777-792.
PMID: 39264472
The section on mesenchymal tumors in the 5th edition of WHO classification of skin tumors has undergone several changes, the most important of which is the inclusion of newly identified...
13.
Agaimy A, Dermawan J, Haller F, Semrau S, Meidenbauer N, Stoehr R, et al.
Virchows Arch
. 2024 Aug;
485(5):805-813.
PMID: 39196362
With the increasing use of innovative next generation sequencing (NGS) platforms in routine diagnostic and research settings, the genetic landscape of uterine sarcomas has been dynamically evolving during the last...
14.
Mickael M, Kubick N, Atanasov A, Martinek P, Horbanczuk J, Floretes N, et al.
Curr Issues Mol Biol
. 2024 Aug;
46(8):8301-8319.
PMID: 39194707
The accurate identification of the primary tumor origin in metastatic cancer cases is crucial for guiding treatment decisions and improving patient outcomes. Copy number alterations (CNAs) and copy number variation...
15.
Dehner C, Pearson H, Almohsen S, Lo Y, Thangaiah J, Torres-Mora J, et al.
Mod Pathol
. 2024 Aug;
37(12):100599.
PMID: 39181449
Acral fibrochondromyxoid tumor (AFCMT) is a recently described likely benign mesenchymal neoplasm arising in the distal extremities with distinctive histologic features and a recurrent THBS1::ADGRF5 fusion. We studied an additional...
16.
Suster D, Mackinnon A, Ronen N, Mejbel H, Harada S, Michal M, et al.
Am J Surg Pathol
. 2024 Jul;
48(10):1215-1223.
PMID: 38989701
A distinctive histological variant of poorly differentiated, sarcomatoid, non-small cell lung carcinoma characterized by a discohesive population of giant tumor cells associated with prominent interstitial inflammatory cell infiltrates is described....
17.
Agaimy A, Stoehr R, Fisher C, Chrisinger J, Demicco E, Togel L, et al.
Am J Surg Pathol
. 2024 Jul;
48(11):1455-1463.
PMID: 38979776
The category of ALK -rearranged mesenchymal neoplasms has been evolving rapidly, with reports of morphologically diverse lesions of cutaneous, soft tissue, and visceral origin. While some of these represent morphologically...
18.
Michal M, Agaimy A, Croce S, Mechtersheimer G, Gross J, Xing D, et al.
Mod Pathol
. 2024 Jun;
37(9):100552.
PMID: 38942115
PLAG1 gene fusions were recently identified in a subset of uterine myxoid leiomyosarcomas (M-LMS). However, we have encountered cases of PLAG1-rearranged uterine sarcomas lacking M-LMS-like morphology and/or any expression of...
19.
Saoud C, Agaimy A, Dermawan J, Chen J, Rosenblum M, Dickson B, et al.
Am J Surg Pathol
. 2024 Jun;
48(10):1302-1317.
PMID: 38934567
GLI1 -altered mesenchymal tumor is a recently described distinct pathologic entity with an established risk of malignancy, being defined molecularly by either GLI1 gene fusions or amplifications. The clinicopathologic overlap...
20.
Kosemehmetoglu K, Mosaieby E, Steiner P, Vanecek T, Baranovska-Andrigo V, Michal M
Genes Chromosomes Cancer
. 2024 Jun;
63(6):e23249.
PMID: 38884173
The widespread use of advanced molecular techniques has led to the identification of several tumor types with PLAG1 gene fusions some of which also affect the skin and soft tissues....